Talphera, Inc. (TLPH): Revenue
$28.0K
Year ended 2025-12-31
$1.0K
Trailing 12 months to 2026-06-30
-65.1%
5-year compound annual growth
-48.0%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.0K | n/a | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | $0 | -100.0% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | $651.0K | n/a | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $0 | -100.0% | 2024-03-06, From 2022-01-01 |
| 2021-12-31 | $2.82M | -48.0% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $5.42M | +136.6% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $2.29M | +6.4% | 2021-03-15, From 2019-01-01 |
| 2018-12-31 | $2.15M | -73.1% | 2021-03-15, From 2018-01-01 |
| 2017-12-31 | $8.00M | -53.9% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $17.36M | -9.9% | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | $19.26M | +269.2% | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | $5.22M | -82.3% | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | $29.50M | n/m | 2016-03-07, From 2013-01-01 |
| 2012-12-31 | $2.39M | +123.3% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $1.07M | n/a | 2014-03-17, From 2011-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Talphera, Inc. (TLPH) | 2025-12-31 | $28.0K | n/a |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $32.0K | n/a |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $21.8K | n/a |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $36.0K | -41.0% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $20.0K | 0.0% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $40.0K | -51.8% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $41.0K | +105.0% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $18.3K | +44.3% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $17.0K | n/a |
Compare TLPH, IBO, JUNS, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗